We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The pharmaceutical industry and federal agencies are completing legal agreements to ensure greater cooperation and information-sharing in the interest of accelerating the development of personalized medicines to treat cancer and other ailments, sources say.
Bristol-Myers Squibb (BMS) and sanofi-aventis have reached a settlement with Apotex over the generic firm’s patent challenge to the blood thinner Plavix.
Pharmaceutical wholesaler Cardinal Health has reached an agreement to acquire Alpharma’s generic drug telemarketing business ParMed Pharmaceuticals for $40.1 million.
Pharmaceutical wholesaler Cardinal Health has reached an agreement to acquire Alpharma’s generic drug telemarketing business ParMed Pharmaceuticals for $40.1 million in cash.
The FTC has approved a final consent order allowing the $7.4 billion merger of Teva Pharmaceutical and Ivax to go forward, the commission announced March 8.
Takeda Pharmaceuticals’ recent court victory against Alphapharm and Mylan Pharmaceuticals over Takeda’s diabetes drug Actos could benefit Andrx, which has a deal with Takeda to develop and market a combination diabetes drug that includes Actos.